“CELLING” THE NEXT BIG THING
Helping the body heal itself – in a nutshell, that’s the science of regenerative medicine, and for many doctors, it’s the future of their practices. We’re Celling Biosciences, and we offer clinician point-of-care products and therapies to advance the science of healing and redefine the global medical landscape.
Our products provide physicians options when they decide to tap into a patient’s capacity for native healing by harvesting cells from the body, processing them and then re-implanting the preparation. In support of this approach, we are focused on developing technology that fulfills the vision associated with concepts like Fusionary™ and Disctoration™. Fusionary™ is a concept that combines a physician’s use of autologous BMC and substrates for achieving bony fusion, while Disctoration™ refers to a physician using autologous BMC and specialized delivery devices to aid in treating degenerative disc disease.
Celling Biosciences has always been committed to offering physicians the most innovative technology for processing bone marrow at their discretion. An important step on our path to innovation was taken when the ART21 ™ device technology was offered to physicians. The ART21 ™ platform greatly improved the ease of use, reliability and reduced sterile breaks for physicians who wanted to concentrate bone marrow.
Celling Biosciences was formed by a team of experts in science, medicine and engineering. Although their backgrounds are diverse, they are guided by a common philosophy: regenerative medicine offers infinite potential to transform the medical landscape and improve the lives of millions.